SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

NowRx, Inc. – ‘1-Z’ on 11/10/22

On:  Thursday, 11/10/22, at 8:03pm ET   ·   As of:  11/14/22   ·   Accession #:  1104659-22-117331

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/14/22  NowRx, Inc.                       1-Z        11/10/22    1:4K                                     Toppan Merrill/FA

Exit Report   —   Form 1-Z   —   Regulation A

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 1-Z         Exit Report -- primary_doc.xml                      HTML      5K


        

This ‘1-Z’ Document is an XML Data File that may be rendered in various formats:

  Form 1-Z    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
SEC Info℠ rendering:  Exit Report
 
schemaVersion:

1-Z: Filer Information

Issuer CIK
0001702206 
Issuer CCC
XXXXXXXX 
File Number
 
Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination? Radio button not checked Yes Radio button checked No
Successor File Number
 
Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST
Is this an electronic copy of an official filing submitted in paper format? Checkbox not checked
Would you like a Return Copy? Checkbox not checked

Submission Contact Information

Name
 
Phone
 
E-Mail Address
 
Notify via Filing Website only? Checkbox not checked

1-Z: PRELIMINARY INFORMATION

Exact name of issuer as specified in the issuer's charter

NowRx, Inc. 

Address of Principal Executive Offices
Address 1

34700 PACIFIC COAST HIGHWAY 

Address 2

STE 203 

City

CAPISTRANO BEACH 

State/Country

CALIFORNIA  

Mailing Zip/ Postal Code

92624 

Phone

650-386-5761 

Commission File Number(s)

024-11605 

Commission File Number(s)

024-11058 

Commission File Number(s)

024-10792 

1-Z: PART I Summary Information Regarding the Offering and Proceeds

Summary Information

Date of qualification of the offering statement

9/29/21 

Date of commencement of the offering

9/29/21 

Amount of securities qualified to be sold in the offering

7002801 

Amount of securities sold in the offering

2621918 

Price per security:

$ 10.5000 

The portion of aggregate sales attributable to securities sold on behalf of the issuer

$ 27530139.00 

The portion of aggregate sales attributable to securities sold on behalf of selling securityholders:

$ 0.00 

Fees in connection with this offering and names of service providers.

Underwriters - Name of Service Provider
SeedInvest Securities LLC
Underwriters - Fees
$ 2153182.00 
Sales Commissions - Name of Service Provider Sales Commissions - Fee
$  
Finders' Fees - Name of Service Provider Finders' Fees - Fees
$  
Accounting or Audit - Name of Service Provider
Fruci & Associates II, PLLC
Accounting or Audit - Fees
$ 51172.00 
Legal - Name of Service Provider
CrowdCheck Law LLP
Legal - Fees
$ 30000.00 
Promoters - Name of Service Provider Promoters - Fees
$  
Blue Sky Compliance - Name of Service Provider Blue Sky Compliance - Fees
$  
CRD Number of any broker or dealer listed

170937 

Net proceeds to the issuer

$ 25295785.00 

Clarification of responses (if necessary):

1-Z: PART II Certification of Suspension of Duty to File Reports

Certification

Title of each class of securities covered by this Form

Series A Preferred Stock

Commission File Number(s)

024-10792 

Approximate number of holders of record as of the certification date

59 

Certification

Title of each class of securities covered by this Form

Series B Preferred Stock

Commission File Number(s)

024-11058 

Approximate number of holders of record as of the certification date

15 

Certification

Title of each class of securities covered by this Form

Series C Preferred Stock

Commission File Number(s)

024-11605 

Approximate number of holders of record as of the certification date

40 

1-Z: Signature

Signature

Pursuant to the requirements of Regulation A,

Cik

0001702206 

(Name of issuer as specified in charter)

NowRx

certifies that it meets all of the conditions for termination of Regulation A reporting specified in Rule 257(d) and that there are no classes of securities other than those that are the subject to this Form 1-Z regarding which the issuer has Regulation A reporting obligations.

(Name of issuer as specified in charter)

NowRx

Has caused this certification to be signed on its behalf by the undersigned duly authorized person.

By

/s/ CaryBreese 

Date

11/10/22 

Title

CEO

Instructions: This Part II of Form 1-Z is required by Rule 257(d) of Regulation A. An officer of the issuer or any other duly authorized person may sign, and must do so by typed signature. The name and title of the person signing the form must be typed or printed under the signature. The signatory to the filing must also manually sign a signature page or other document authenticating, acknowledging or otherwise adopting his or her signature that appears in the filing. Such document must be executed before or at the time the filing is made and must be retained by the issuer for a period of five years. Upon request, the issuer must furnish to the Commission or its staff a copy of any or all documents retained pursuant to this instruction.


↑Top
Filing Submission 0001104659-22-117331   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., Apr. 20, 5:18:23.1am ET